Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 14, 2026 09:51 ET | Source: Research and Markets

$191.2 Million Achromatopsia Market Outlook, 2026-2032, Featuring Adverum Biotechnologies, Homology Medicines, Mattel, REGENXBIO, Sanofi and More

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Achromatopsia Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Achromatopsia Market is experiencing...
January 14, 2026 09:46 ET | Source: Research and Markets

Artificial Iris Market Outlook 2026-2032: A $36.92 Million Global Opportunity

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Artificial Iris Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artificial Iris Market has shown...
January 14, 2026 09:09 ET | Source: Spherix Global Insights

Spherix Global Insights Highlights Evolving PD-1 Landscape as Subcutaneous Use Grows and Biosimilars Approach across Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Exton, PA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights reports new findings from its inaugural Market Dynamix™: PD-1 Inhibition in Solid Tumors (US) study, based on quantitative and...
January 13, 2026 10:27 ET | Source: Research and Markets

AI Optical Coherence Tomography Market Opportunities to 2029 & 2034 by Type, Technology, Application and Region

Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) Optical Coherence Tomography (OCT) Market Report 2025" has been added to ResearchAndMarkets.com's offering. The...
January 13, 2026 07:00 ET | Source: Ocugen

Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data

MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...
January 13, 2026 03:15 ET | Source: Bio Usawa Inc

Bio Usawa Receives Ghana FDA Approval for BioUcenta™

ACCRA, Ghana and KIGALI, Rwanda, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd. (Bio Usawa, Inc.) today announced that the Ghana Food and Drugs Authority (Ghana FDA) has approved...
January 12, 2026 08:00 ET | Source: Gradalis, Inc.

Gradalis Appoints Steven D. Weinstein as Chief Executive Officer

Weinstein brings more than two decades of experience in life sciences leadership, venture capital, and company buildingProven track record of guiding innovative healthcare organizations from...
January 12, 2026 07:00 ET | Source: IRIDEX Corporation

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

MOUNTAIN VIEW, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
January 12, 2026 06:50 ET | Source: ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities

For full year 2025, total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS expected to be within or above guidance ranges of $854 million to $873 million, $221 million to $228...
January 12, 2026 06:30 ET | Source: Ocugen

Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy

Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in Stargardt disease patients MALVERN, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) --...